Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment. It occurs unexpectedly and is occasionally fatal. It can occur after an autogeneic or an allogeneic hematopoietic cell transplantation.
Biomarker and diagnostic research for engraftment syndrome has been reported in the published literature.
2 clinical trials registered. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
35 publications have been identified in PubMed for engraftment syndrome. Research spans Clinical Trial Publication (23%), Epidemiology / Natural History (23%), and Diagnostic / Biomarker (17%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 8 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:03 PM UTC
Genetic and Rare Diseases Info Center
Disease patterns and progression | 8 | 23% |
Testing and diagnosis research | 6 | 17% |
Research summaries | 4 | 11% |
Patient case studies | 4 | 11% |
Laboratory research | 4 | 11% |
Other research | 1 | 3% |
Choi H (2026). [PMID: 41171505](https://pubmed.ncbi.nlm.nih.gov/41171505/). *Int J Hematol*. [Case Report / Case Series]
Zhang W (2026). [PMID: 41664553](https://pubmed.ncbi.nlm.nih.gov/41664553/). *Clin Transplant*. [Epidemiology / Natural History]
Zhou XH (2026). [PMID: 41766157](https://pubmed.ncbi.nlm.nih.gov/41766157/). *Zhongguo Dang Dai Er Ke Za Zhi*. [Review / Meta-Analysis]
Smith MA (2026). [PMID: 41248753](https://pubmed.ncbi.nlm.nih.gov/41248753/). *Transplant Cell Ther*. [Basic Science / Preclinical]
Politikos I (2025). [PMID: 40423982](https://pubmed.ncbi.nlm.nih.gov/40423982/). *Blood Adv*. [Clinical Trial Publication]
Zhang XL (2025). [PMID: 40754028](https://pubmed.ncbi.nlm.nih.gov/40754028/). *Clin Immunol*. [Diagnostic / Biomarker]
Wang S (2025). [PMID: 40275517](https://pubmed.ncbi.nlm.nih.gov/40275517/). *Pediatr Blood Cancer*. [Clinical Trial Publication]
Alnughmush A (2025). [PMID: 39802196](https://pubmed.ncbi.nlm.nih.gov/39802196/). *Transplant Direct*. [Diagnostic / Biomarker]
Horan DE (2025). [PMID: 40119584](https://pubmed.ncbi.nlm.nih.gov/40119584/). *Pediatr Blood Cancer*. [Diagnostic / Biomarker]
Gloe L (2025). [PMID: 39985640](https://pubmed.ncbi.nlm.nih.gov/39985640/). *Support Care Cancer*. [Epidemiology / Natural History]